USANA Health Sciences, Inc. (USNA) 当前追踪市盈率 (P/E) 为 30.1, 前瞻市盈率为 10.9. 追踪盈利收益率为 3.32%, 前瞻盈利收益率 9.21%. PEG 0.05 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $20.58.
本页证实的标准:
SharesGrow 综合评分： 64/100 其中 3/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | 15.0 | 1.46 | 4.61 | 1.49 | - |
| 2017 | 28.4 | -0.78 | 4.90 | 1.70 | - |
| 2018 | 22.0 | 0.21 | 7.09 | 2.33 | - |
| 2019 | 17.7 | -1.03 | 5.06 | 1.68 | - |
| 2020 | 13.0 | 0.40 | 3.67 | 1.43 | - |
| 2021 | 17.5 | -9.37 | 5.16 | 1.72 | - |
| 2022 | 14.8 | -0.39 | 2.36 | 1.03 | - |
| 2023 | 16.2 | -2.16 | 2.08 | 1.12 | - |
| 2024 | 16.2 | -0.48 | 1.28 | 0.80 | - |
| 2026 | 33.6 | -0.46 | 0.68 | 0.39 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2019 | $4.41 | $1.06B | $100.53M | 9.5% |
| 2020 | $5.86 | $1.13B | $124.66M | 11% |
| 2020 | $5.86 | $1.13B | $124.66M | 11% |
| 2021 | $5.73 | $1.19B | $116.51M | 9.8% |
| 2021 | $5.73 | $1.19B | $116.51M | 9.8% |
| 2022 | $3.59 | $998.6M | $69.35M | 6.9% |
| 2023 | $3.30 | $921.01M | $63.79M | 6.9% |
| 2023 | $3.30 | $921.01M | $63.79M | 6.9% |
| 2024 | $2.19 | $854.5M | $42.03M | 4.9% |
| 2025 | $0.58 | $925.26M | $10.76M | 1.2% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $1.74 | $1.74 – $1.74 | $925.02M | $925.02M – $925.02M | 1 |
| 2027 | $2.00 | $2.00 – $2.00 | $942.45M | $942.45M – $942.45M | 1 |
| 2028 | $2.77 | $2.77 – $2.77 | $1B | $1B – $1B | 1 |
